Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Pharmint logo — Global B2B pharmaceutical Marketplace and supply chain makin...

Pharmint

Global B2B pharmaceutical Marketplace and supply chain making pharma Accessible and Affordable to everyone!

Founded 2021 Singapore Singapore 44 employees Seed Total: $100.00K E-Commerce, Pharmaceutical

General Information

Company Name Pharmint
Founded Year 2021
Location Singapore Singapore
Employees 44
Industries E-Commerce, Pharmaceutical
Funding Stage Seed
Business Model B2B, Marketplace, E Commerce
Revenue Model Marketplace Fee, Service Fee, Membership
Social

BounceWatch is an independent company data service, not affiliated with Pharmint. To contact Pharmint, visit pharmint.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Product Launch Sep 26, 2026

Pharmint has launched a Pembrolizumab Biosimilar Development: Sourcing and Manufacturing Guide, providing practical insights into biosimilar development and sourcing processes.

Get alerts when Pharmint shows new signals

AI Insight

Bounce Watch AI
23 hours ago

Pharmint is strategically evolving its B2B pharmaceutical marketplace by planning the launch of a Pembrolizumab Biosimilar Development Guide in September 2026. This future product signifies a pivotal shift towards specializing in high-value, complex segments like biosimilar development and sourcing, moving beyond a generic marketplace to become a key enabler in specific, lucrative pharma supply chains. This specialization highlights a dynamic strategy to capture a more sophisticated customer base and deepen industry expertise, projecting a clear path for future growth.

Signal Types
Product Launch Strategy Shift
Strategic Labels
Market Specialization Biosimilar Focus B2B Platform Evolution
Next Move: Fundraising
·
Impact: 8/10
·
Ideal For: Specialized Pharma Tech VCs – Pre-Seed/Seed

About Pharmint

Pharmint is a Singapore-based startup founded in 2022 that aims to revolutionize the pharmaceutical industry through its integrated B2B Pharma Marketplace. With its slogan "Global B2B pharmaceutical supply chain making pharma Accessible and Affordable to everyone!", Pharmint is focused on creating a more accessible and affordable pharmaceutical supply chain on a global scale. The startup received its last investment in a Pre Seed Round on 01 July 2023, with Draper Startup House as the lead investor. Pharmint operates within the E-Commerce and Pharmaceutical industries, positioning itself as a key player in the intersection of technology and healthcare. This strategic positioning, coupled with the support of reputable investors, positions Pharmint as a promising venture with the potential to disrupt the pharmaceutical supply chain.

Taxonomy: pharmaceutical, global, marketplace, cross-border, accessible, affordable

Services & Products

Bulk Medical Supplies
Cross-Border Pharma Trade
Request Bulk Quotations
Product Cost Calculator
Price Comparison Tools
Verified Buyer-Seller Messaging

Target Customers

Pharmaceutical Importers Medical Equipment Suppliers Pharmaceutical Exporters API Suppliers Healthcare Product Buyers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $100.00K 1
Antler
Antler
01 Apr 2022

Pharmint Alternatives & Competitors

Pharmint vs
PharmaHopers Pvt. Ltd.
PharmaHopers Pvt. Ltd. India

PharmaHopers is a complete B2B Pharmaceutical marketplace in India

48 employees
E-Commerce, Pharmaceutical
Pharmint vs
Drugdu.com
Drugdu.com China

Drugdu.com is a leading global pharmaceutical and medical devices B2B online platform.

28 employees
B2B, E-Commerce
Pharmint vs
Pipelinepharma
Pipelinepharma Lithuania

The only CTD dossier market intelligence and sourcing platform.

Seed
14 employees
B2B, E-Commerce

FAQ About Pharmint

Global B2B pharmaceutical Marketplace and supply chain making pharma Accessible and Affordable to everyone!
Pharmint was founded in 2021.
Pharmint is headquartered in Singapore.
Pharmint operates in E-Commerce and Pharmaceutical. Its work centres on pharmaceutical, global, marketplace and cross-border. Its customers include Pharmaceutical Importers, Medical Equipment Suppliers and Pharmaceutical Exporters.
Pharmint has a B2B, Marketplace and E Commerce business model. Its revenue comes from Marketplace Fee, Service Fee and Membership.
Pharmint has approximately 44 employees.
Pharmint has completed 1 funding round, raising a total of $100.00K. The latest funding stage is Seed.
Pharmint offers: Bulk Medical Supplies, Cross-Border Pharma Trade, Request Bulk Quotations, Product Cost Calculator, Price Comparison Tools, Verified Buyer-Seller Messaging.
Top alternatives and competitors to Pharmint include PharmaHopers Pvt. Ltd., Drugdu.com, Pipelinepharma, Farmazon, 1药网. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharmint and PharmaHopers Pvt. Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pharmint, https://bouncewatch.com/company/pharmint, updated 29 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes